Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
  • BioNTech
    Mergers & Acquisitions
    $67M
  • Merck
    Mergers & Acquisitions
    $2.7BN
  • Incyte
    Licensing Agreement
    $900M
  • NeuroBo Pharmaceuticals
    Mergers & Acquisitions
    Undisclosed
  • Lilly
    Mergers & Acquisitions
    $1.1BN
  • Pfizer
    Partnership
    $150M
  • Altavant Sciences
    Mergers & Acquisitions
    Undisclosed
  • Almirall
    Mergers & Acquisitions
    $15M
  • Galen
    Mergers & Acquisitions
    Undisclosed
  • Merck
    Licensing Agreement
    $50M
  • BeiGene
    Partnership
    Undisclosed
  • Biocon
    Mergers & Acquisitions
    $100M
  • AstraZeneca
    Licensing Agreement
    $181M
  • Global Blood Therapeutics
    Partnership
    $375M
  • Freeline
    Capital Raising
    $80M
  • CytoDyn
    Licensing Agreement
    $87.5M
  • CRUK
    Licensing Agreement
    Undisclosed
  • Charles River Laboratories
    Mergers & Acquisitions
    $380M
  • Roche
    Mergers & Acquisitions
    $4.8BN
  • Promethera Biosciences
    Capital Raising
    $52.47M
  • Almirall
    Partnership
    Undisclosed
  • Novartis
    Licensing Agreement
    Undisclosed
  • Sanofi
    Partnership
    Undisclosed
  • Amneal Pharmaceuticals
    Mergers & Acquisitions
    $340M
  • AbbVie
    Partnership
    Undisclosed
  • Merck
    Mergers & Acquisitions
    $2.7BN
  • Boehringer Ingelheim
    Partnership
    Undisclosed
  • Sanofi
    Mergers & Acquisitions
    $2.5BN
  • Janssen Biotech
    Licensing Agreement
    $750M
  • Vedanta Biosciences
    Partnership
    $5.8M

DEALS ANALYSIS

DEALS NEWS

Close
Close
Close

Go Top